ACB
EHC icon

Aristotle Capital Boston’s Encompass Health EHC Stock Holding History

Aristotle Capital Boston’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.8M Sell
49,252
-1,078
-2% -$111K 0.3% 99
2025
Q4 		$5.34M Sell
50,330
-4,342
-8% -$503K 0.29% 99
2025
Q3 		$6.94M Sell
54,672
-3,748
-6% -$446K 0.36% 94
2025
Q2 		$7.16M Sell
58,420
-11,057
-16% -$1.26M 0.36% 89
2025
Q1 		$7.04M Sell
69,477
-27,292
-28% -$2.66M 0.35% 88
2024
Q4 		$8.94M Sell
96,769
-8,218
-8% -$807K 0.33% 91
2024
Q3 		$10.1M Sell
104,987
-28,042
-21% -$2.52M 0.34% 90
2024
Q2 		$11.4M Sell
133,029
-34,136
-20% -$2.86M 0.38% 87
2024
Q1 		$13.8M Sell
167,165
-12,632
-7% -$925K 0.42% 87
2023
Q4 		$12M Sell
179,797
-22,729
-11% -$1.47M 0.37% 99
2023
Q3 		$13.6M Sell
202,526
-3,823
-2% -$263K 0.44% 87
2023
Q2 		$14M Buy
206,349
+9,010
+5% +$565K 0.42% 89
2023
Q1 		$10.7M Buy
197,339
+12,228
+7% +$712K 0.33% 105
2022
Q4 		$11.1M Sell
185,111
-7,013
-4% -$381K 0.35% 103
2022
Q3 		$8.69M Sell
192,124
-93,182
-33% -$4.66M 0.29% 114
2022
Q2 		$12.7M Buy
285,306
+25,553
+10% +$1.31M 0.38% 109
2022
Q1 		$14.7M Buy
259,753
+174
+0.1% +$9.09K 0.37% 109
2021
Q4 		$13.5M Buy
259,579
+30,170
+13% +$1.56M 0.32% 115
2021
Q3 		$13.7M Buy
229,409
+33,747
+17% +$2.12M 0.32% 112
2021
Q2 		$12.1M Sell
195,662
-4,586
-2% -$306K 0.28% 118
2021
Q1 		$13M Buy
200,248
+19,984
+11% +$1.3M 0.29% 115
2020
Q4 		$11.9M Buy
180,264
+25,163
+16% +$1.48M 0.28% 112
2020
Q3 		$8.02M Buy
155,101
+13,090
+9% +$672K 0.23% 116
2020
Q2 		$7M Buy
+142,011
New +$7.66M 0.21% 118

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Aristotle Capital Boston's EHC Position: Q1 2026 in Review

Aristotle Capital Boston reduced its Encompass Health (EHC) stake by 2.1% in Q1 2026, selling an estimated $111K and leaving 49,252 shares worth $4.8M. The position accounts for 0.3% of the portfolio, ranked #99.

Aristotle Capital Boston first reported a position in EHC in Q2 2020 and has held it in 24 quarters since. The position peaked at $14.7M in Q1 2022. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Aristotle Capital Boston held 49,252 shares of Encompass Health worth $4.8M as of Q1 2026.
  • Aristotle Capital Boston sold 1,078 Encompass Health shares in Q1 2026, an estimated $111K.
  • Encompass Health made up 0.3% of Aristotle Capital Boston's portfolio in Q1 2026, its #99 holding.
  • Aristotle Capital Boston first reported a position in Encompass Health in Q2 2020 and has held it in 24 quarters since.
  • Aristotle Capital Boston's Encompass Health position peaked at $14.7M in Q1 2022.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.